what are the different glp-1 drugs Comparing Ozempic, Wegovy and Other The Rise of GLP-1 Medications
Description
This means an independent third-party organization, not Anthem, reviews your case and makes a binding decision
& Chou, P
& Li, Y
Lancet 397 , 17361748 (2021)
The SELECT trial, which evaluated semaglutide 2.4 mg against placebo for cardiovascular outcomes in patients with overweight and obesity without type 2 diabetes, showed significant decreases in total cholesterol, LDL-C, and triglycerides and an increase in HDL-C at 39.8 months [48]
